Stock listing
Sionna Therapeutics, Inc.
Selected listing: SION · NASDAQ · USD · US
Sionna Therapeutics, Inc. (NASDAQ:SION), Health Technology. Latest release Sep 14, 2026: Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222…
- Ticker
- NASDAQ:SION
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. is a public company traded under the ticker SION in the American market. Sionna Therapeutics focuses on developing innovative therapies in the healthcare sector.
Latest news from Sionna Therapeutics, Inc.
Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial
September 14, 2026
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
August 6, 2026
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
May 27, 2026
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
Research Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. company profile
View the public company page for Sionna Therapeutics, Inc. on 6ix.
Sionna Therapeutics, Inc. news
Read company news and market updates connected to Sionna Therapeutics, Inc..
Sionna Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sionna Therapeutics, Inc..